Journal Clinical Nurse Specialist: The Journal for Advanced Nursing Practice

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Smelling Salts Use and Abuse - Evidence and Myths for Practice
Price: $17.95
Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0125

Published: Jan/Feb 2025

Expires: 12/4/2026

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 8/10 (80%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Advanced Pharmacology Hours , Advanced Practice Nursing , Drug Therapy , Evidence Based Practice

Specialties: Advanced Practice Nursing, Evidence-based practice, Pharmacy

Topics: Ammonia-Based Inhalants , Drug Abuse , Medication Safety , Medications , Smelling Salts

Media:
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Beetroot Supplementation: How Much? How Long? How Safe? Real Evidence for Practice Rather Than Media Hype
Price: $21.95
Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS1124

Published: Nov/Dec 2024

Expires: 12/4/2026

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 8/10 (80%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Advanced Practice Nursing , Drug Therapy , Evidence Based Practice , Nutrition

Specialties: Advanced Practice Nursing, Evidence-based practice, Nutrition

Topics: Beet Root Supplementation , Dietary Recommendations , Nutrition Science

Media:
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Shortages After 10 years - Sorry, Nothing Has Changed
Price: $17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0924

Published: Sep/Oct 2024

Expires: 9/5/2025

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 5/6 (83%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Drug Therapy , Pharmacology

Specialties: Pharmacy, Public Health

Topics: Drug Shortages , Drug Update

Media:
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy
Price: $17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0524

Published: May/Jun 2024

Expires: 6/6/2025

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 8/10 (80%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Advanced Practice Nursing , Cardiovascular , Drug Therapy

Specialties: Advanced Practice Nursing, Cardiology

Topics: Drug Update , Hypertrophic Cardiomyopathy

Media:
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rather Than Prescribing - How About Deprescribing? Providing Safe Care for Patients Lost in the Maze of Polypharmacy
Price: $17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0324

Published: Mar/Apr 2024

Expires: 6/6/2025

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 8/10 (80%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Advanced Practice Nursing , Drug Therapy

Specialties: Advanced Practice Nursing, Primary Care

Topics: Deprescribing , Polypharmacy

Media:
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} ZURZUVAE - The First Oral Treatment Approved for Postpartum Depression
Price: $17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0124

Published: Jan/Feb 2024

Expires: 3/7/2025

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 8/10 (80%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Advanced Practice Nursing , Drug Therapy , Gynecological , Obstetrics , Psychosocial/Psychiatric , Women's Health

Specialties: Advanced Practice Nursing, Gynecology, Maternal-Child, OB/GYN, Obstetrics, Psychiatric and Mental Health, Women's Health

Topics: Drug Update , Mental Health , Postpartum Depression

Media:
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Nonhormonal Selective NK3R Antagonist for Moderate to Severe Vasomotor Symptoms in Menopause
Price: $17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS1123

Published: Nov/Dec 2023

Expires: 12/5/2025

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 7/10 (70%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Advanced Practice Nursing , Drug Therapy , Gynecological , Women's Health

Specialties: Advanced Practice Nursing, Gynecology, OB/GYN, Women's Health

Topics: Gynecologic , Hormone Therapy , Menopause , Nonhormonal Selective Neurokinin-3 Receptor Antagonist , Vasomotor Symptoms

Media:
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rising Xylazine Drug Abuse in Humans: A Deep and Lingering High With Wounds, Amputations, and Death
Price: $17.95
Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0723

Published: Jul/Aug 2023

Expires: 6/6/2025

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 7/10 (70%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Addiction , Advanced Practice Nursing

Specialties: Addiction, Advanced Practice Nursing

Topics: Xylazine
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Food and Drug Administration Accelerated Approval of Lecanemab for Early Alzheimer's Disease - Hope, Reality, and the Unknown Going Forward
Price: $17.95
Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0523

Published: May/Jun 2023

Expires: 6/6/2025

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 8/10 (80%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Collections: CESaver

Categories: Advanced Pharmacology Hours , Advanced Practice Nursing , Geriatrics , Neurological

Specialties: Advanced Practice Nursing, Gerontology, Neurology

Topics: Alzheimer Disease , Drug Update
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} So Where is a Vaccine for Respiratory Syncytial Virus?
Price: $17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: CNS0323

Published: Mar/Apr 2023

Expires: 3/7/2025

Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Details

Required Passing Score: 8/10 (80%)

Authors: Patricia Anne O'Malley, PhD, APRN-CNS

Categories: Advanced Practice Nursing , Pediatrics , Respiratory , Virology

Specialties: Advanced Practice Nursing, Community Health, Home Health, Infectious Diseases, Medical-Surgical, Pediatrics, Primary Care, Public Health, Pulmonary

Topics: Respiratory Syncytial Virus (RSV) , Vaccinations

Viewing 1–10 of 18

«
of 2
»

CEConnection

Journal Clinical Nurse Specialist: The Journal for Advanced Nursing Practice

Show

Sort

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Smelling Salts Use and Abuse - Evidence and Myths for Practice

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Beetroot Supplementation: How Much? How Long? How Safe? Real Evidence for Practice Rather Than Media Hype

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Shortages After 10 years - Sorry, Nothing Has Changed

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rather Than Prescribing - How About Deprescribing? Providing Safe Care for Patients Lost in the Maze of Polypharmacy

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} ZURZUVAE - The First Oral Treatment Approved for Postpartum Depression

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Nonhormonal Selective NK3R Antagonist for Moderate to Severe Vasomotor Symptoms in Menopause

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rising Xylazine Drug Abuse in Humans: A Deep and Lingering High With Wounds, Amputations, and Death

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Food and Drug Administration Accelerated Approval of Lecanemab for Early Alzheimer's Disease - Hope, Reality, and the Unknown Going Forward

Credits:

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} So Where is a Vaccine for Respiratory Syncytial Virus?

Credits: